Explore
Validate
LearnPA5-20385
antibody from Invitrogen Antibodies
Targeting: SLPI
ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4
Western blot
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-20385 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- SLPI Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A suggested positive control is Daudi cell lysate. PA5-20385 can be used with blocking peptide PEP-0502.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 1 mg/mL
- Storage
- Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C
Submitted references Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFα secretion.
De Santis S, Kunde D, Serino G, Galleggiante V, Caruso ML, Mastronardi M, Cavalcanti E, Ranson N, Pinto A, Campiglia P, Santino A, Eri R, Chieppa M
Oncotarget 2016 Nov 15;7(46):75800-75809
Oncotarget 2016 Nov 15;7(46):75800-75809
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5 SLPI is expressed in human inflamed intestinal tract and further induced following quercetin exposure A-D. Representative immunohistochemistry images for SLPI expression in normal (panels A and B) and inflamed (panels C and D) human intestinal biopsies. FFPE sections were prepared at 20 mum thickness, stained for Slpi and visualized using BioCare polymer IHC kit. E. SLPI expression was measured on human normal and inflamed areas by qPCR relative to untreated non-inflamed biopsies. Bars represent mean +- SEM (n=7). **P
